These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 31337360)

  • 41. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.
    Reznicek L; Cserhati S; Seidensticker F; Liegl R; Kampik A; Ulbig M; Neubauer AS; Kernt M
    Acta Ophthalmol; 2013 Nov; 91(7):e529-36. PubMed ID: 23647578
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic Factors for Functional and Anatomic Outcomes in Patients with Diabetic Macular Edema Treated with Dexamethasone Implant.
    Lee H; Kang KE; Chung H; Kim HC
    Korean J Ophthalmol; 2018 Apr; 32(2):116-125. PubMed ID: 29560616
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Behavior of SD-OCT Detectable Hyperreflective Foci in Diabetic Macular Edema Patients after Therapy with Anti-VEGF Agents and Dexamethasone Implants.
    Rübsam A; Wernecke L; Rau S; Pohlmann D; Müller B; Zeitz O; Joussen AM
    J Diabetes Res; 2021; 2021():8820216. PubMed ID: 33937416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RETINAL LAYER RESPONSE TO RANIBIZUMAB DURING TREATMENT OF DIABETIC MACULAR EDEMA: Thinner is Not Always Better.
    Ebneter A; Wolf S; Abhishek J; Zinkernagel MS
    Retina; 2016 Jul; 36(7):1314-23. PubMed ID: 26735563
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Panretinal photocoagulation after or prior to intravitreal conbercept injection for diabetic macular edema: a retrospective study.
    Zhang W; Zhao G; Fan W; Zhao T
    BMC Ophthalmol; 2021 Apr; 21(1):160. PubMed ID: 33789617
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A systematic review and meta-analysis to compare the efficacy of conbercept with ranibizumab in patients with macular edema secondary to retinal vein occlusion.
    Liu W; Li Y; Cao R; Bai Z; Liu W
    Medicine (Baltimore); 2020 May; 99(21):e20222. PubMed ID: 32481293
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic Efficacy of Intravitreal Conbercept Injections with or without Focal Macular Photocoagulation for Diabetic Macular Edema.
    Mao Y; Wang S; Ji X; Cao K; Hou S; Xiao Y
    Altern Ther Health Med; 2023 Jul; 29(5):308-313. PubMed ID: 37171942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optical Coherence Tomography-Based Grading of Diabetic Macular Edema Is Associated with Systemic Inflammatory Indices and Imaging Biomarkers.
    Yanxia C; Xiongyi Y; Min F; Xiaoyun K
    Ophthalmic Res; 2024; 67(1):96-106. PubMed ID: 38211574
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Morphological and functional changes in recalcitrant diabetic macular oedema after intravitreal dexamethasone implant.
    Iacono P; Parodi MB; Scaramuzzi M; Bandello F
    Br J Ophthalmol; 2017 Jun; 101(6):791-795. PubMed ID: 27625164
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative efficacy of anti-vascular endothelial growth factor on diabetic macular edema diagnosed with different patterns of optical coherence tomography: A network meta-analysis.
    Yao J; Huang W; Gao L; Liu Y; Zhang Q; He J; Zhang L
    PLoS One; 2024; 19(6):e0304283. PubMed ID: 38848379
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural and functional assessment after intravitreal injection of ranibizumab in diabetic macular edema.
    Fu Y; Wang P; Meng X; Du Z; Wang D
    Doc Ophthalmol; 2017 Dec; 135(3):165-173. PubMed ID: 28756595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diabetic macular edema with neuroretinal detachment: OCT and OCT-angiography biomarkers of treatment response to anti-VEGF and steroids.
    Vujosevic S; Toma C; Villani E; Muraca A; Torti E; Florimbi G; Leporati F; Brambilla M; Nucci P; De Cilla' S
    Acta Diabetol; 2020 Mar; 57(3):287-296. PubMed ID: 31541333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytokine and Chemokine Profile Changes in Patients After Intravitreal Conbercept Injection for Diabetic Macular Edema.
    Wei Q; Wan Z; Hu Y; Peng Q
    Drug Des Devel Ther; 2019; 13():4367-4374. PubMed ID: 31920286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IMPACT OF LONG-TERM INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ON PREEXISTING MICROSTRUCTURAL ALTERATIONS IN DIABETIC MACULAR EDEMA.
    Wirth MA; Wons J; Freiberg FJ; Becker MD; Michels S
    Retina; 2018 Sep; 38(9):1824-1829. PubMed ID: 28767550
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optical coherence tomography classifications of diabetic macular edema and response to aflibercept: One-year follow-up outcomes in a Chinese population.
    Gu Z; Xi T; Zhang C; Yang G
    Medicine (Baltimore); 2023 Jan; 102(4):e32815. PubMed ID: 36705371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A real-world study for timely assessing the diabetic macular edema refractory to intravitreal anti-VEGF treatment.
    Hsieh TC; Deng GH; Chang YC; Chang FL; He MS
    Front Endocrinol (Lausanne); 2023; 14():1108097. PubMed ID: 37265702
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract.
    Akinci A; Muftuoglu O; Altınsoy A; Ozkılıc E
    Retina; 2011 Apr; 31(4):755-8. PubMed ID: 21124251
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the efficacy of anti-vascular endothelial growth factors in diabetic macular edema with retinal inner and outer layers disorganization.
    Kocapınar Y; Kaplan FB; Demirciler Sönmez A; Açıkalın B
    Acta Diabetol; 2023 Oct; 60(10):1391-1398. PubMed ID: 37378699
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NATURAL HISTORY AND PREDICTORS OF VISION LOSS IN EYES WITH DIABETIC MACULAR EDEMA AND GOOD INITIAL VISUAL ACUITY.
    Lent-Schochet D; Lo T; Luu KY; Tran S; Wilson MD; Moshiri A; Park SS; Yiu G
    Retina; 2021 Oct; 41(10):2132-2139. PubMed ID: 33734192
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aflibercept in diabetic macular edema refractory to previous bevacizumab: outcomes and predictors of success.
    Laiginhas R; Silva MI; Rosas V; Penas S; Fernandes VA; Rocha-Sousa A; Carneiro Â; Falcão-Reis F; Falcão MS
    Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):83-89. PubMed ID: 29082448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.